scorecardresearch
Add as a preferred source on Google
Saturday, September 12, 2026
Celebrating 9 Years
Support Our Journalism

Support our Journalism

9th Anniversary: Free Tote & Mug

Subscribe
TopicTuberculosis

Topic: Tuberculosis

One TB gene fooled scientists for decades. It does more than they expected

The misunderstood enzyme lies dormant for long periods of time, but under the right conditions it begins acting extremely fast.

India’s homegrown malaria vaccine still a couple of years away from potential rollout, says ICMR chief

While the indigenous malaria vaccine, AdFalciVax, is under evaluation, a dengue vaccine is currently in Phase 3 trials with final results expected by the end of next year.

Century after last TB vaccine, India’s Serum Institute partners with Gates MRI for novel jab

Tuberculosis remains world’s deadliest infectious disease despite being preventable and curable. Around 1.23 million of 10.7 million who developed it in 2024 died, says WHO.

Why ICMR wants Centre’s TB programme to screen for hidden lung infection often mistaken for tuberculosis

A new multi-centre study, funded by ICMR & published in The Lancet, flags Nontuberculous Mycobacterial disease as an emerging public health problem.

Revisiting the Lakshadweep strategy—How India’s smallest UT got tuberculosis-free status

As of mid-2026, no Indian state has achieved TB-free certification. New book explains that Lakshadweep’s achievement did not come through expensive tech or complex interventions. 

India topped global TB cases in 2023. Study in Lancet warns multidrug-resistant cases stalling progress

A new analysis estimates India had 2.22 million TB cases in 2023, while warning that drug-resistant TB continues to undermine global efforts despite falling overall cases and deaths.

A TB death-prediction tool has worked in Tamil Nadu. It’s yet to be picked up for national rollout

ICMR-NIE's TB death-prediction tool, described in a study published in British medical journal The BMJ Open, estimates the probability of early TB death within two months of diagnosis.

How Indian firm Lupin became the world-leading TB medicine maker

Manish Sabharwal and Sundeep Khanna's 'Made in India' is the untold story of Desh Bandhu Gupta, Lupin, and how India became the pharmacy to the world.

New antibiotic stokes hope for world’s deadliest, but curable disease – TB

In high-burden countries like India, for every person diagnosed and treated, about two go undiagnosed.

Bringing dramatic drop in TB deaths, how TN set an example for rest of India with one-of-a-kind model

Differentiated TB care involves tailoring services to individual needs of patients. Researchers pitch it as a model that can be replicated across the country.

On Camera

Srinagar’s cinemas may have gone dark. Kashmir’s love for films never did

It seemed like J&K's battered past had taken a backseat, even if it was for the four days of the international film festival.

Global funds sour on India stocks as some cut allocation to zero

Weak corporate earnings and the lack of an AI investment theme are prompting global investors to cut India exposure.

‘Society as battlefield’: NATO cites Indian military paper on cognitive warfare. What it says

In a seminal work, former military officers Lt. Gen. D.S. Hooda & Lt. Col. Pavithran Rajan put forth a framework to approach cognitive warfare, called Socio-Technical-Cognitive Battlespace.

The real BRICS story is what China, Russia want & India wishes

India, China and Russia share more contradictions than congruence. Each has a different worldview, as also a different adversary. The rude fact is that BRICS is the most irrelevant of all such groupings.